Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung…
NCT00003589 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003589 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer |
| Official title | Randomized Study With New Combination Chemotherapies in Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, gemcitabine hydrochloride, paclitaxel |
| Enrollment | 450 |
| Start date | Aug 1, 1998 |
| Primary completion | Jul 1, 2000 |
| First posted | Jul 13, 2004 |
| Last update posted | Mar 6, 2012 |
| Countries | Belgium, Czechia, Egypt, France, Germany, Greece, Italy, Netherlands, Poland, South Africa, Spain, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: